Regulatory integration is a central aspect of European integration. Yet the debate about a “European regulatory state” (Majone 1996, 1992; McGowan and Wallace 1996; Begg 1996; and Wilks 1996) largely avoids a fundamental question: who in this emerging “European regulatory state” translates the intent of EU decisions into action? Who disposes of the capacities-organizational, professional, financial, information and communication-necessary for implementing EU regulatory policy? While recent research on the role of European agencies begins to address this issue at the European level (Shapiro 1997; Majone 1997; Dehousse 1997; Kreher 1997; McGowan and Wallace 1996), the findings are often specific to the policy sector (Héritier et al. 1996; Ame...
International audienceThis paper focuses on the European Regulatory system which was settled both fo...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
Regulatory integration is a central aspect of European integration. Yet the debate about a “European...
A complex relationship exists among EU regulations, current national practices and rules, institutio...
A complex relationship exists among EU regulations, current national practices and rules, institutio...
A complex relationship exists among EU regulations, current national practices and rules, institutio...
"The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it ach...
A complex relationship exists among EU regulations, current national practices and rules, institutio...
'The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it ach...
One objective of this paper is to understand the nature and the role of policy networks and multi-le...
One objective of this paper is to understand the nature and the role of policy networks and multi-le...
Defence date: 31 October 2014Examining Board: Professor Adrienne Héritier, European University Insti...
One objective of this paper is to understand the nature and the role of policy networks and multi-le...
International audienceThis paper focuses on the European Regulatory system which was settled both fo...
International audienceThis paper focuses on the European Regulatory system which was settled both fo...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
Regulatory integration is a central aspect of European integration. Yet the debate about a “European...
A complex relationship exists among EU regulations, current national practices and rules, institutio...
A complex relationship exists among EU regulations, current national practices and rules, institutio...
A complex relationship exists among EU regulations, current national practices and rules, institutio...
"The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it ach...
A complex relationship exists among EU regulations, current national practices and rules, institutio...
'The EC harmonized market entry regulation for pharmaceuticals from the early sixties on, but it ach...
One objective of this paper is to understand the nature and the role of policy networks and multi-le...
One objective of this paper is to understand the nature and the role of policy networks and multi-le...
Defence date: 31 October 2014Examining Board: Professor Adrienne Héritier, European University Insti...
One objective of this paper is to understand the nature and the role of policy networks and multi-le...
International audienceThis paper focuses on the European Regulatory system which was settled both fo...
International audienceThis paper focuses on the European Regulatory system which was settled both fo...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...
This paper provides a comparison of European Union regulatory policy for pharmaceuticals and medical...